SNX9 Inhibits Cell Proliferation and Cyst Development in Autosomal Dominant Polycystic Kidney Disease via Activation of the Hippo-YAP Signaling Pathway

Bendris, 2017, Endocytosis, metastasis and beyond: multiple facets of SNX9., Trends Cell Biol., 27, 189, 10.1016/j.tcb.2016.11.001

Bendris, , Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells., J. Cell Sci., 129, 2804, 10.1242/jcs.188045

Bendris, , SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases., Mol. Biol. Cell, 27, 1409, 10.1091/mbc.e16-02-0101

Bergmann, 2018, Polycystic kidney disease., Nat. Rev. Dis. Prim., 4

Cai, 2018, A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease., Genes Dev., 32, 781, 10.1101/gad.315127.118

Chebib, 2016, Autosomal dominant polycystic kidney disease: core curriculum 2016., Am. J. Kidney Dis., 67, 792, 10.1053/j.ajkd.2015.07.037

Hansch, 2020, Chlamydia-induced curvature of the host-cell plasma membrane is required for infection., Proc. Natl. Acad. Sci. U.S.A., 117, 2634, 10.1073/pnas.1911528117

Hao, 2008, Tumor suppressor LATS1 is a negative regulator of oncogene YAP., J. Biol. Chem., 283, 5496, 10.1074/jbc.m709037200

Happe, 2011, Altered Hippo signalling in polycystic kidney disease., J. Pathol., 224, 133, 10.1002/path.2856

Ibrahim, 2007, Increased apoptosis and proliferative capacity are early events in cyst formation in autosomal-dominant, polycystic kidney disease., Sci. World J., 7, 1757, 10.1100/tsw.2007.274

Ish-Shalom, 2016, Impaired SNX9 expression in immune cells during chronic inflammation: prognostic and diagnostic implications., J. Immunol., 196, 156, 10.4049/jimmunol.1402877

Jiao, 2014, A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer., Cancer Cell, 25, 166, 10.1016/j.ccr.2014.01.010

Jing, 2018, Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway., Am. J. Physiol. Renal Physiol., 315, F479, 10.1152/ajprenal.00329.2017

LaRiviere, 2015, Novel therapeutic approaches to autosomal dominant polycystic kidney disease., Transl. Res., 165, 488, 10.1016/j.trsl.2014.11.003

Loghman-Adham, 2003, Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts., Am. J. Physiol. Renal Physiol., 285, F397, 10.1152/ajprenal.00310.2002

Ma, 2018, Polycystic kidney disease: a Hippo connection., Genes Dev., 32, 737, 10.1101/gad.316570.118

Malekshahabi, 2019, Autosomal dominant polycystic kidney disease: disrupted pathways and potential therapeutic interventions., J. Cell. Physiol., 234, 12451, 10.1002/jcp.28094

Mangoo-Karim, 1989, Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP., Proc. Natl. Acad. Sci. U.S.A., 86, 6007, 10.1073/pnas.86.15.6007

Mo, 2014, The Hippo signaling pathway in stem cell biology and cancer., EMBO Rep., 15, 642, 10.15252/embr.201438638

Muller, 2019, Hippo signaling-a central player in cystic kidney disease?, Pediatr. Nephrol., 35, 1143, 10.1007/s00467-019-04299-3

Nandez, 2014, A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells., eLife, 3, 10.7554/eLife.02975

Padovano, 2018, Metabolism and mitochondria in polycystic kidney disease research and therapy., Nat. Rev. Nephrol., 14, 678, 10.1038/s41581-018-0051-1

Park, 2015, Alternative Wnt signaling activates YAP/TAZ., Cell, 162, 780, 10.1016/j.cell.2015.07.013

Román-Fernández, 2018, The phospholipid PI(3,4)P(2) is an apical identity determinant., Nat. Commun., 9, 10.1038/s41467-018-07464-8

Sasaki, 2017, Sorting Nexin 9 facilitates podocin endocytosis in the injured podocyte., Sci. Rep., 7, 10.1038/srep43921

Shi, 2018, Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKbeta-AMPK-mTOR pathway in ADPKD cells., Mol. Cell. Biochem., 449, 219, 10.1007/s11010-018-3358-0

Shin, 2008, SNX9 regulates tubular invagination of the plasma membrane through interaction with actin cytoskeleton and dynamin 2., J. Cell Sci., 1252, 10.1242/jcs.016709

Soulet, 2005, SNX9 regulates dynamin assembly and is required for efficient clathrin-mediated endocytosis., Mol. Biol. Cell, 16, 2058, 10.1091/mbc.e04-11-1016

Tanigawa, 2019, SNX9 determines the surface levels of integrin beta1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9., J. Cell Physiol., 234, 17280, 10.1002/jcp.28346

Tanigawa, 2019, SNX9 determines the surface levels of integrin beta1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9., J. Cell. Physiol., 234, 17280, 10.1002/jcp.28346

Wang, 2015, Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling., FASEB J., 29, 1551, 10.1096/fj.14-260828

Weiler, 2017, Induction of chromosome instability by activation of yes-associated protein and forkhead box M1 in liver cancer., Gastroenterology, 152, 2037, 10.1053/j.gastro.2017.02.018

Wilson, 2004, Polycystic kidney disease: new understanding in the pathogenesis., Int. J. Biochem. Cell Biol., 36, 1868, 10.1016/j.biocel.2004.03.012

Yang, 2018, Interactions between macrophages and cyst-lining epithelial cells promote kidney cyst growth in Pkd1-deficient mice., J. Am. Soc. Nephrol., 29, 2310, 10.1681/asn.2018010074

Yarar, 2008, SNX9 activities are regulated by multiple phosphoinositides through both PX and BAR domains., Traffic, 9, 133, 10.1111/j.1600-0854.2007.00675.x

Yu, 2015, Hippo pathway in organ size control, tissue homeostasis, and cancer., Cell, 163, 811, 10.1016/j.cell.2015.10.044

Zhao, 2010, The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version., Genes Dev., 24, 862, 10.1101/gad.1909210